JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 15, 2009; DOI: 10.1124/jpet.109.151183


0022-3565/09/3301-220-226$20.00
JPET 330:220-226, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.109.151183v1
330/1/220    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Horak, S.
Right arrow Articles by Striessnig, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horak, S.
Right arrow Articles by Striessnig, J.

NEUROPHARMACOLOGY

Use-Dependent Block of Voltage-Gated Cav2.1 Ca2+ Channels by Petasins and Eudesmol Isomers

Silja Horak, Alexandra Koschak, Hermann Stuppner, and Jörg Striessnig

Pharmacognosy (S.H., H.S.) and Pharmacology and Toxicology (A.K., J.S.), Institute of Pharmacy, Innsbruck, Austria; and Center of Biomolecular Sciences Innsbruck (S.H., A.K., H.S., J.S.), University of Innsbruck, Austria

Migraine is a frequent and often disabling disease. Treatment is unsatisfactory in many patients. A disturbed dynamic balance between excitatory and inhibitory signal processing with enhanced cortical activity probably underlies common forms of migraine. Presynaptic voltage-gated Ca2+ channels are critical determinants of neurotransmitter release and also contribute to trigeminovascular signal transduction. Because clinical evidence exists for migraine-prophylactic actions of Petasites hybridus extracts, we investigated whether petasins comprising the main constituents of the extract inhibit currents through presynaptic Cav2.1 channels expressed in Xenopus laevis oocytes. P. hybridus extract (0.02 mg/ml), petasin, neopetasin, isopetasin, S-petasin, and iso-S-petasin (50 µM) were weak tonic blockers of Cav2.1-mediated barium currents (IBa) during infrequent depolarizations (0.1 Hz), but their inhibitory potency increased at higher stimulation rates (1 Hz), indicating preferential block of open and/or inactivated channels. Sulfur-containing compounds (S-petasin, Iso-S-petasin) were the most potent significantly promoting the accumulation of Cav2.1 channel in inactivated states during pulse trains (IBa decrease during 1-Hz pulse trains: control, 45%, S-petasin, 79%; iso-S-petasin, 80%). For the Eucalyptus williamsiania sesquiterpenes {alpha}- and {gamma}-eudesmol, a comparable use-dependent inhibition was found in addition to a tonic block component. {alpha}-Eudesmol and petasins accelerated the voltage-dependent inactivation of Cav2.1 channels during depolarizations. We demonstrate that S-petasin, iso-S-petasin, and eudesmol are Cav2.1 channel inhibitors preferentially acting as use-dependent channel blockers and with the sulfur-containing substituent in position 3 of the petasins serving as important functional feature. The Cav2.1-inhibitory properties of these petasins may contribute to migraine-prophylactic properties described for P. hybridus extracts.


Received for publication January 20, 2009
Accepted April 14, 2009.

Address correspondence to: Jörg Striessnig, Pharmacology and Toxicology, Institute of Pharmacy, Peter-Mayr-Strasse 1/I, A-6020 Innsbruck, Austria. E-mail: joerg.striessnig{at}uibk.ac.at







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.